+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bifurcation Lesions Market Size, Share & Trends Analysis Report, By Application, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Bifurcation Lesions Market Size, Share & Trends Analysis Report, By Application, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Bifurcation Lesions Market Size, Share & Trends Analysis Report, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 5893308
Description Jump to:

Bifurcation Lesions Market Growth & Trends

The global bifurcation lesions market size is expected to reach USD 3.5 billion by 2030, registering a CAGR of 6.0% from 2025 to 2030. Technological developments and supportive government initiatives for reimbursement are likely to drive the market during the forecast period.

The increasing geriatric population and unhealthy lifestyle are responsible for growth in the incidence of cardiovascular disorders. Furthermore, an increase in approval & commercialization of innovative devices and the expected entry of new devices for the treatment of bifurcation lesions in the coming years are likely to drive the market.

In addition, factors such as rising affordability, increase in demand for minimally invasive procedures, and growing medical tourism are also boosting demand for bifurcation lesions procedures across the globe. According to various studies, procedures for coronary bifurcation lesions comprise approximately 20% of total percutaneous coronary interventions.

Bifurcation Lesions Market Report Highlights

  • Increase in the commercialization of devices for bifurcation lesions and investments by industry players for R&D are the factors expected to boost the market, resulting in an anticipated CAGR of around 6.0% from 2025 to 2030
  • The coronary vascular segment accounted for the maximum share of the market in 2024 due to the presence of complex vascular network in heart, increased availability of devices, and rise in awareness regarding surgical interventions for bifurcation lesions.
  • The peripheral vascular segment is likely to witness lucrative growth in the coming years due to an increase in investments by industry players for the development of devices for peripheral application and advancements in diagnostics facilitating accurate detection of plaque.
  • Geographically, North America held the largest share of the bifurcation lesions market in 2024. It is anticipated to maintain its dominance in the coming years due to increasing demand for drug-eluting stents, commercialization of devices for bifurcation lesions, and the local presence of major market players.
  • The Asia Pacific is expected to observe the fastest growth over the next decade owing to improvement in healthcare infrastructure, medical tourism, and a rise in investments by market players in the region.
  • Some of the key players in the market are Abbott; Boston Scientific Corporation; Cardinal Health; Medtronic; Johnson & Johnson Services, Inc.; C. R. Bard, Inc.; Spectranetics; and Terumo Medical Corporation. Tryton Medical, Inc. developed the Tryton Side Branch Stent with a balloon-expandable, single-wire stent delivery system that can be deployed in the side branch artery for treatment of bifurcation lesions. The device is available in the U.S. and Europe as well as Middle East & Africa.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Regional scope
1.2.3. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Segment
2.2.2. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Bifurcation Lesions Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of congenital heart disease
3.2.1.2. Increasing number of CVD incidence
3.2.1.3. Increasing awareness among the population
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatment
3.2.2.2. Limited awareness and adoption
3.3. Bifurcation Lesions Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Bifurcation Lesions Market: Application Estimates & Trend Analysis
4.1. Bifurcation Lesions Market: Application Dashboard
4.2. Bifurcation Lesions Market: Application Movement Analysis
4.3. Bifurcation Lesions Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Coronary
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Peripheral
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Bifurcation Lesions Market: Regional Estimates & Trend Analysis by Application, and Region
5.1. Global Bifurcation Lesions Market: Regional Dashboard
5.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
5.3. North America
5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2. U.S.
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Canada
5.3.3.1. Key country dynamics
5.3.3.2. Regulatory framework/ reimbursement structure
5.3.3.3. Competitive scenario
5.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
5.3.4. Mexico
5.3.4.1. Key country dynamics
5.3.4.2. Regulatory framework/ reimbursement structure
5.3.4.3. Competitive scenario
5.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
5.4. Europe
5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. UK
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
5.4.3. Germany
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
5.4.4. France
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
5.4.5. Italy
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
5.4.6. Spain
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
5.4.8. Norway
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
5.4.9. Denmark
5.4.9.1. Key country dynamics
5.4.9.2. Regulatory framework/ reimbursement structure
5.4.9.3. Competitive scenario
5.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3. Japan
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4. India
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5. Australia
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6. Thailand
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7. South Korea
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
5.6. Latin America
5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6.2. Brazil
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
5.6.3. Argentina
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
5.7. MEA
5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
5.7.3. South Africa
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
5.7.4. UAE
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
5.7.5. Kuwait
5.7.5.1. Key country dynamics
5.7.5.2. Regulatory framework/ reimbursement structure
5.7.5.3. Competitive scenario
5.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Manufacturers
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2023
6.3.4. Boston Scientific Corp.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Abbott
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Cardinal Health
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Medtronic
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. C. R. Bard, Inc.
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Johnson & Johnson Services, Inc.
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Spectranetics
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Terumo Medical Corp.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Tryton Medical Inc.
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Global bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 4 Global bifurcation lesions market, by region, 2018 - 2030 (USD Million)
Table 5 North America bifurcation lesions market, by country, 2018 - 2030 (USD Million)
Table 6 North America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 7 U.S. bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 8 Canada bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 9 Mexico bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 10 Europe bifurcation lesions market, by country, 2018 - 2030 (USD Million)
Table 11 Europe bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 12 UK bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 13 Germany bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 14 France bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 15 Italy bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 16 Spain bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 17 Denmark bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 18 Sweden bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 19 Norway bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 20 Asia Pacific bifurcation lesions market, by country, 2018 - 2030 (USD Million)
Table 21 Asia Pacific bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 22 Japan bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 23 China bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 24 India bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 25 Australia bifurcation lesions market, by country, 2018 - 2030 (USD Million)
Table 26 Australia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 27 Thailand bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 28 South Korea bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 29 Latin America bifurcation lesions market, by country, 2018 - 2030 (USD Million)
Table 30 Latin America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 31 Brazil bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 32 Argentina bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 33 MEA bifurcation lesions market, by country, 2018 - 2030 (USD Million)
Table 34 MEA bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 35 South Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 36 Saudi Arabia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 37 UAE bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 38 Kuwait bifurcation lesions market, by application, 2018 - 2030 (USD Million)
Table 39 Participant’s overview
Table 40 Financial performance
Table 41 Key companies undergoing expansions
Table 42 Key companies undergoing acquisitions
Table 43 Key companies undergoing collaborations
Table 44 Key companies launching new product types
Table 45 Key companies undergoing partnerships
Table 46 Key companies undertaking other strategies
List of Figures
Fig. 1 Bifurcation lesions market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Bifurcation lesions market outlook, 2024 (USD Million)
Fig. 10 Market Trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Bifurcation lesions application market share analysis, 2024 - 2030 (USD Million)
Fig. 14 Bifurcation lesions application market: Segment dashboard
Fig. 15 Coronary market, 2018 - 2030 (USD Million)
Fig. 16 Peripheral market, 2018 - 2030 (USD Million)
Fig. 17 Regional marketplace: Key takeaways
Fig. 18 North America bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 19 U.S. bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 20 Canada bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 21 Mexico bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 22 Europe bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 23 UK bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 24 Germany bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 25 France bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 26 Italy bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 27 Spain bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 28 Denmark bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 29 Sweden bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 30 Norway bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 31 Asia Pacific bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 32 Japan bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 33 China bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 34 India bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 35 Australia bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 36 South Africa bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 37 Thailand bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 38 Latin America bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 39 Brazil bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 40 Argentina bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 41 MEA bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 42 South Africa bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 43 Saudi Arabia bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 44 UAE bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 45 Kuwait bifurcation lesions market, 2018 - 2030 (USD Million)
Fig. 46 Strategy framework

Companies Mentioned

  • Boston Scientific Corp.
  • Abbott
  • Cardinal Health
  • Medtronic
  • C. R. Bard, Inc.
  • Johnson & Johnson Services, Inc.
  • Spectranetics
  • Terumo Medical Corp.
  • Tryton Medical Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages90
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.5 billion
Forecasted Market Value ( USD ) by 2030 $ 3.5 billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Bifurcation Lesions Market by Type, Application - Global Forecast 2025-2030 - Product Image

Bifurcation Lesions Market by Type, Application - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Bifurcation Lesions Market Report by Types, Application, and Region 2024-2032 - Product Image

Bifurcation Lesions Market Report by Types, Application, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Bifurcation Lesions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Bifurcation Lesions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From
Bifurcation Lesions - Global Strategic Business Report - Product Image

Bifurcation Lesions - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Bifurcation Lesions Market Report 2025 - Product Image

Bifurcation Lesions Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.